Summary & Overview
CPT 0546T: Radiofrequency Spectroscopy for Margin Assessment After Partial Mastectomy
CPT code 0546T covers intraoperative radiofrequency spectroscopy imaging used after a partial mastectomy or lumpectomy to assess whether surgical margins are free of cancer. This technology-driven adjunct aims to reduce re-excision rates by providing real-time information about margin status, making it relevant for surgical oncology practice and payers overseeing breast-conserving therapy. Nationally, the code reflects growing interest in intraoperative margin assessment tools and their potential impact on quality measures and episode costs.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents, typical sites of service, and the clinical context for use. The publication outlines coverage and reimbursement benchmarks where available, highlights policy developments affecting adoption and coding, and situates the service within surgical workflow for breast-conserving procedures.
This summary presents clinical and billing context for administrators, coding staff, and policy analysts seeking concise information about CPT code 0546T, including how the technology is positioned within operative care and what aspects of payer policy and utilization are most relevant for national stakeholders.
Billing Code Overview
CPT code 0546T describes the use of radiofrequency spectroscopy imaging performed immediately after a partial mastectomy or lumpectomy to assess surgical margins for residual cancer. The procedure uses electromagnetic-wave–based spectroscopy to evaluate the excised specimen or the surgical cavity to determine whether margins are free of tumor cells.
Service Type: Intraoperative margin assessment / surgical adjunct imaging
Typical Site of Service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A 52-year-old woman undergoes a breast-conserving surgery (partial mastectomy/lumpectomy) for a biopsy-proven early-stage invasive ductal carcinoma. Intraoperative frozen section or permanent pathology is not yet definitive for margin status, so the surgical team employs radiofrequency spectroscopy immediately after the excision to assess the surgical margins for residual tumor at the cavity edge. The procedure is performed in an operating room or ambulatory surgical center under general or regional anesthesia as part of the index surgical encounter. The device provides real-time information to guide the surgeon in obtaining additional tissue from areas with a positive or close signal, with the goal of achieving negative margins and reducing the need for re-excision. Typical workflow: preoperative imaging and biopsy, operative lumpectomy/partial mastectomy, intraoperative radiofrequency spectroscopy evaluation of margins (0546T), targeted additional excision if spectroscopy indicates positive or close margins, and specimen submission for permanent pathology confirmation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When the radiofrequency spectroscopy is unusually complex or requires substantially greater effort than typical. |